Oncolytics Biotech Reports Positive Translational Data for Pelareorep in Anal Cancer Study

Article summary

Oncolytics Biotech announced new translational data from an ongoing study showing that its lead candidate, pelareorep, increases HPV-16-specific T cell and tumor-infiltrating lymphocyte clones in patients with squamous cell anal cancer.